Alpha 2.0
Login Register
» Articles » PMID: 6015903

Dietary Treatment in Tyrosinemia (tyrosinosis). With a Note on the Possible Recognition of the Carrier State

Overview
Journal Am J Dis Child
Publisher American Medical Association
Specialty Pediatrics
Date 1967 Jan 1
PMID 6015903
Citations 11
Authors
J GENTZ
B Lindblad
S Lindstedt
L Levy
W Shasteen
R Zetterstrom
Affiliations
Soon will be listed here.
Citing Articles

Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.

Grompe M, Overturf K, Finegold M J Inherit Metab Dis. 1998; 21(5):518-31.

PMID: 9728332 DOI: 10.1023/a:1005462804271.

Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.

Sassa S, Kappas A J Clin Invest. 1983; 71(3):625-34.

PMID: 6826727 PMC: 436912. DOI: 10.1172/jci110809.

Recovery after dietary treatment of an infant with features of tyrosinosis.

HARRIES J, Seakins J, Ersser R, Lloyd J Arch Dis Child. 1969; 44(234):258-67.

PMID: 5779435 PMC: 2020051. DOI: 10.1136/adc.44.234.258.

Diagnosis and treatment of tyrosinosis.

Fairney A, Francis D, Ersser R, Seakins J, Cottom D Arch Dis Child. 1968; 43(231):540-7.

PMID: 5696464 PMC: 2020014. DOI: 10.1136/adc.43.231.540.

Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.

Manabe S, Sassa S, Kappas A J Exp Med. 1985; 162(3):1060-74.

PMID: 3928801 PMC: 2187807. DOI: 10.1084/jem.162.3.1060.